跳至主要内容
临床试验/NCT02405637
NCT02405637Unknown1 期

Enteral Administration of a Simulated Amniotic Fluid In Preventing Feeding Intolerance And Necrotizing Enterocolitis In Very Low Birth Weight Neonates

Rania Ali El-Farrash1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2014年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
发起方
入组人数
40
试验地点
1
主要终点
Necrotizing enterocolitis by modified Bell criteria, mortality in percentage, hospital stay in days. The outcome measure will be assessed within 2 months

研究概览

简要总结

The human fetus swallows over 200 ml of amniotic fluid per kilogram of weight each day and such swallowing is essential for normal small bowel development.Growth factors found in the amniotic fluid have been shown to promote proliferation of fetal intestinal cells. As feeding intolerance is a common problem among premature neonates, the investigators will study the role of enteral administration of simulated amniotic fluid solution in prevention of feeding intolerance and NEC in premature neonates.

详细描述

Very Low Birth Weight (VLBW) neonates.

Participants will be followed for the duration of hospital stay until discharge or death.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
28 Weeks 至 36 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Premature infants with birth weight 1.5 Kg

排除标准

  • Congenital or acquired anomaly of the gastrointestinal tract (i.e., omphalocele, tracheoesophageal fistula, intestinal perforation).
  • Other major congenital anomalies (congenital heart disease, neural tube defect, congenital diaphragmatic hernia, trisomy, etc.).

研究组 & 干预措施

SAFE group

Experimental

simulated amniotic fluid 20cc/kg/day enterally divided according to number of feds (syringe for every fed). This amount provides enteral 4.5μg rhG-CSF / kg/day and enteral 88IU rhEPO / kg/day.

干预措施: simulated amniotic fluid 20cc/kg/day enterally (Drug)

placebo

Placebo Comparator

distilled water 2.5 ml/kg every 3 hours enterally

干预措施: distilled water (Drug)

结局指标

主要结局

Necrotizing enterocolitis by modified Bell criteria, mortality in percentage, hospital stay in days. The outcome measure will be assessed within 2 months

时间窗: participants will be followed for the duration of hospital stay, an expected average of 4 weeks

次要结局

未报告次要终点

研究者

发起方
Rania Ali El-Farrash
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Rania Ali El-Farrash

Enteral Administration of a Simulated Amniotic Fluid In Preventing Feeding Intolerance And Necrotizing Enterocolitis In Very Low Birth Weight Neonates

Ain Shams University

研究点 (1)

Loading locations...

相似试验